(Q30403507)

21 June 2017

1 reference

title

Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans (English)

1 reference

21 June 2017

0 references

Garry W Lynch

1

1 reference

21 June 2017

Paul Selleck

series ordinal

2

1 reference

21 June 2017

W Bret Church

series ordinal

3

1 reference

21 June 2017

John S Sullivan

series ordinal

4

1 reference

21 June 2017

publication date

7 June 2011

1 reference

Immunology & Cell Biology

21 June 2017

published in

1 reference

21 June 2017

volume

90

1 reference

21 June 2017

issue

2

1 reference

21 June 2017

page(s)

149-158

1 reference

Pandemic potential of a strain of influenza A (H1N1): early findings

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

The persistent legacy of the 1918 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Conserved amino acid markers from past influenza pandemic strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: a public health risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

A universal epitope-based influenza vaccine and its efficacy against H5N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Structure, Receptor Binding, and Antigenicity of Influenza Virus Hemagglutinins from the 1957 H2N2 Pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Evaluation of Southern Hemisphere influenza vaccine recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Potential targets and their relevant inhibitors in anti-influenza fields.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Structure and functions of influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Antiviral therapy for influenza : a clinical and economic comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Immunity to influenza in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Pandemic influenza: an inconvenient mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

What can we learn from reconstructing the extinct 1918 pandemic influenza virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

1918 Influenza: the mother of all pandemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Control of influenza virus infection by immunity to conserved viral features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Heterosubtypic immunity to influenza A virus: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Characterization of the 1918 "Spanish" influenza virus neuraminidase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Influence of prior influenza vaccination on antibody and B-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Cross-reactive Antibodies against avian influenza virus A (H5N1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Cytotoxic T-cell immunity to influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Hallmarks of CD4 T cell immunity against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Cross-protective immunity to influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Universal vaccines: shifting to one for many

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Structural basis of influenza virus neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Avian Influenza A (H5N1) Age Distribution in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Antibody recognition of a highly conserved influenza virus epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

B cells and aging: molecules and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Human innate immunosenescence: causes and consequences for immunity in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Influenza-induced production of interferon-alpha is defective in geriatric individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Complications of seasonal and pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Immunogenetics of seasonal influenza vaccine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Ab and T cell epitopes of influenza A virus, knowledge and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Influenza hemagglutinin and neuraminidase membrane glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Localization of the influenza virus nucleoprotein: cell-associated and extracellular non-virion forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Human domain antibodies to conserved sterically restricted regions on gp120 as exceptionally potent cross-reactive HIV-1 neutralizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Identification of human-to-human transmissibility factors in PB2 proteins of influenza A by large-scale mutual information analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Influenza virus vaccine based on the conserved hemagglutinin stalk domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

HIV-1 and influenza antibodies: seeing antigens in new ways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

Characterization of a highly pathogenic avian influenza H5N1 virus sublineage in poultry seized at ports of entry into Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

7 January 2021

Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

7 January 2021

A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

7 January 2021

Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2011.38

7 January 2021

Identifiers

DOI

10.1038/ICB.2011.38

1 reference

Dimensions Publication ID

21 June 2017

1016211358

0 references

1 reference